Loading...
 
Toggle Health Problems and D

3X less likely to die of COVID-19 if good level of vitamin D (seniors in Boston)– March 8, 2021

Association of vitamin D status with hospital morbidity and mortality in adult hospitalized COVID-19 patients

Endocr Pract . 2021 Mar 8;S1530-891X(21)00057-4. doi: 10.1016/j.eprac.2021.02.013.
Nipith Charoenngam, MD; Arash Shirvani, MD, PhD; Niyoti Reddy, MBBS; Danica M. Vodopivec, MD; Caroline M. Apovian, MD; Michael F. Holick, MD

Highlights

  • It has been proposed that vitamin D is an immunomodulatory agent that is protective against severity of COVID-19.
  • We found an independent association between serum 25-hydroxyvitamin D ≥30 ng/mL and decreased risk of mortality from COVID-19 in elderly patients and patients without obesity.
  • It is advisable to maintain serum 25-hydroxyvitamin D at least 30 ng/mL to reduce the risk of developing severe COVID-19.

Image

Image
Non-statistically significant rows are not shown above

VitaminDWiki

COVID-19 treated by Vitamin D - studies, reports, videos

As of Jan 31, 2024, the VitaminDWiki COVID page had:  19+ trial results,   37+ meta-analyses and reviews,   Mortality studies   see related:   Governments,   HealthProblems,   Hospitals,  Dark Skins,   All 26 COVID risk factors are associated with low Vit D,   Fight COVID-19 with 50K Vit D weekly   Vaccines   Take lots of Vitamin D at first signs of COVID   166 COVID Clinical Trials using Vitamin D (Aug 2023)   Prevent a COVID death: 9 dollars of Vitamin D or 900,000 dollars of vaccine - Aug 2023
5 most-recently changed Virus entries

Virus meta-analyses


Also by Holick on COVID-19 include:

Vitamin D, Zinc, etc. look promising for COVID-19 (Holick) – Jan 25, 2021
Call for immediate action - Fight COVID-19 with vitamin D (up to 4,000 IU) - Jan 28, 2021
Rate of COVID-19 test positive is 40 pcnt lower if high vitamin D (192,000 people) - Holick Sept 2020

    • Image

 Download the PDF from VitaminDWiki

Objective
To determine the association between vitamin D status and morbidity and mortality in adult hospitalized COVID-19 patients

Methods
We performed a retrospective chart review study in COVID-19 patients aged ≥18 years old hospitalized at Boston University Medical Center between March 1 – August 4, 2020. All studied patients were tested positive for COVID-19 and had serum levels of 25-hydroxyvitamin D results measured within one year prior to the date of positive tests. Medical information was retrieved from the electronic medical record and were analyzed to determine the association between vitamin D status and hospital morbidity and mortality.

Results
Among the 287 patients, 100 (36%) patients were vitamin D-sufficient [25(OH)D >30 ng/mL] and 41 (14%) patients died during the hospitalization. Multivariate analysis in patients aged ≥65 years old revealed that

  • vitamin D sufficiency [25(OH)D ≥30 ng/mL] was statistically significantly associated
    • with decreased odds of death (adjusted OR 0.33, 95%CI, 0.12–0.94),
  • acute respiratory distress syndrome (adjusted OR 0.22, 95%CI, 0.05–0.96), and
  • severe sepsis/septic shock (adjusted OR 0.26, 95%CI, 0.08–0.88),

after adjustement for potential confounders.
Among patients with body mass index <30 kg/m 2, vitamin D sufficiency was statistically significantly associated with a decreased odds of death (adjusted OR 0.18, 95%CI, 0.04–0.84). No significant association was found in the subgroups of patients aged <65 years old or BMI ≥30 kg/m 2.

Conclusion
We revealed an independent association between vitamin D sufficiency defined by serum 25(OH)D ≥30 ng/mL and decreased risk of mortality from COVID-19 in elderly patients and patients without obesity.


Created by admin. Last Modification: Friday March 12, 2021 18:34:58 GMT-0000 by admin. (Version 9)

Attached files

ID Name Comment Uploaded Size Downloads
15232 significant Boston outcomes.jpg admin 12 Mar, 2021 61.98 Kb 320
15231 Boston table.jpg admin 12 Mar, 2021 42.79 Kb 315
15230 Boston.pdf admin 12 Mar, 2021 739.77 Kb 300